PRGO Q2 2019 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.1B-3.2% YoY

Gross Profit

$431M37.5% margin

Operating Income

$55M4.8% margin

Net Income

$9M0.8% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-2.2%

Cash Flow

Operating Cash Flow

$64M

Free Cash Flow

$30M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$11.4B

Total Liabilities

$5.7B

Stockholders' Equity

$5.7B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$1.2B	-3.2%
Gross Profit	$431M	$471M	-8.5%
Operating Income	$55M	$95M	-41.9%
Net Income	$9M	$36M	-75.1%

Revenue Segments

Consumer Self-Care Americas

$582M51%

Consumer Self-Care International

$328M29%

RX Pharmaceuticals

$239M21%

Geographic Segments

UNITED STATES

$769M66%

Europe

$316M27%

Other Geographical Areas

$65M6%

IRELAND

$7M1%